FKN improves microglial erythrophagocytosis via the CD163/heme oxygenase-1 (HO-1) axis, thus mitigating neuroinflammation, hematoma size and Hb content and relieving neurological deficits in ICH mice (128, 129). The gene discussed is HMOX1; the disease is hematoma.